Wilkie, M and Davies, S ORCID: https://orcid.org/0000-0001-5127-4755 (2018) Does alanyl-glutamine supplementation offer potential to improve peritoneal dialysate biocompatibility? Kidney International, 94 (6). 1050 -1052.

[img] Text
KI-09-18-1286.pdf - Accepted Version
Restricted to Repository staff only until 19 November 2019.
Available under License Creative Commons Attribution Non-commercial No Derivatives.

Download (248kB)

Abstract

Peritoneal dialysis technique survival remains challenging due to peritonitis and long-term alterations to peritoneal membrane function and integrity. Up to now, the development of less bio-incompatible dialysis solutions have not had a major impact on these aspects of the therapy. A novel approach, supplementing dialysis solutions with a cytoprotective additive, alanyl-glutamine, has shown benefits to surrogate biomarkers of cell function in a randomized controlled study.

Item Type: Article
Additional Information: This is the accepted author manuscript (AAM). The final published version (version of record) is available online via Elsevier at http://doi.org.10.1016/j.kint.2018.09.012 - please refer to any applicable terms of use of the publisher.
Uncontrolled Keywords: peritonitis, peritoneal dialysis, dialysis
Subjects: R Medicine > RC Internal medicine > RC902 Nephrology
Divisions: Faculty of Medicine and Health Sciences > Institute for Science and Technology in Medicine
Related URLs:
Depositing User: Symplectic
Date Deposited: 04 Feb 2019 09:10
Last Modified: 04 Feb 2019 09:13
URI: http://eprints.keele.ac.uk/id/eprint/5747

Actions (login required)

View Item View Item